101 related articles for article (PubMed ID: 20541691)
1. The challenge of drug-rechallenge: Facts and controversies.
Davidovici BB; Wolf R
Clin Dermatol; 2010; 28(3):349-53. PubMed ID: 20541691
[TBL] [Abstract][Full Text] [Related]
2. Danger signs in drug hypersensitivity.
Scherer K; Bircher AJ
Med Clin North Am; 2010 Jul; 94(4):681-9, xv-x. PubMed ID: 20609857
[TBL] [Abstract][Full Text] [Related]
3. [Cutaneous reactions to drugs].
Mulder WM; Meinardi MM; Bruynzeel DP
Ned Tijdschr Geneeskd; 2004 Feb; 148(9):415-20. PubMed ID: 15038200
[TBL] [Abstract][Full Text] [Related]
4. Negative predictive value of drug skin tests in investigating cutaneous adverse drug reactions.
Waton J; Tréchot P; Loss-Ayav C; Schmutz JL; Barbaud A
Br J Dermatol; 2009 Apr; 160(4):786-94. PubMed ID: 19120340
[TBL] [Abstract][Full Text] [Related]
5. [Cutaneous adverse drug reactions: enhanced imputation score by skin testing].
Choquet-Kastylevsky G; Vial T; Santolaria N; Nageotte A; Faure M; Claudy A; Descotes J
Ann Dermatol Venereol; 2001 Apr; 128(4):507-11. PubMed ID: 11395648
[TBL] [Abstract][Full Text] [Related]
6. Cutaneous drug reactions.
Rubianes EI; Martín RF; Picó M; González JR
Bol Asoc Med P R; 1990 Oct; 82(10):434-42. PubMed ID: 2150483
[TBL] [Abstract][Full Text] [Related]
7. Usefulness of skin testing in cutaneous drug eruptions in routine practice.
Tchen T; Reguiaï Z; Vitry F; Arnoult E; Grange A; Florent G; Bernard P
Contact Dermatitis; 2009 Sep; 61(3):138-44. PubMed ID: 19780771
[TBL] [Abstract][Full Text] [Related]
8. Multiple drug allergy in patients with cutaneous adverse drug reactions diagnosed by in vitro drug-induced interferon-gamma release.
Halevy S; Grossman N
Isr Med Assoc J; 2008 Dec; 10(12):865-8. PubMed ID: 19160944
[TBL] [Abstract][Full Text] [Related]
9. Combined in vivo and in vitro approach for the characterization of penicillin-specific polyclonal lymphocyte reactivity: tolerance tests with safe penicillins instead of challenge with culprit drugs.
Sachs B; Al Masaoudi T; Merk HF; Erdmann S
Br J Dermatol; 2004 Oct; 151(4):809-16. PubMed ID: 15491421
[TBL] [Abstract][Full Text] [Related]
10. [Relevance of nerve blocks in treating and diagnosing low back pain--is the quality decisive?].
Hildebrandt J
Schmerz; 2001 Dec; 15(6):474-83. PubMed ID: 11793154
[TBL] [Abstract][Full Text] [Related]
11. [Skin tests in the study of drug eruptions with suspected immuno-allergic mechanism].
Barbaud A; Béné MC; Faure G; Schmutz JL
Bull Acad Natl Med; 2000; 184(4):775-91. PubMed ID: 10989563
[TBL] [Abstract][Full Text] [Related]
12. Oral challenge in patients with suspected cutaneous adverse drug reactions: findings in 784 patients during a 25-year-period.
Lammintausta K; Kortekangas-Savolainen O
Acta Derm Venereol; 2005; 85(6):491-6. PubMed ID: 16396795
[TBL] [Abstract][Full Text] [Related]
13. The usefulness of skin tests to prove drug hypersensitivity.
Lammintausta K; Kortekangas-Savolainen O
Br J Dermatol; 2005 May; 152(5):968-74. PubMed ID: 15888154
[TBL] [Abstract][Full Text] [Related]
14. Generalized pustular drug eruptions: confirmation by in vitro tests.
Lazarov A; Livni E; Halevy S
J Eur Acad Dermatol Venereol; 1998 Jan; 10(1):36-41. PubMed ID: 9552755
[TBL] [Abstract][Full Text] [Related]
15. A refined symptom-based approach to diagnose pulmonary tuberculosis in children.
Marais BJ; Gie RP; Hesseling AC; Schaaf HS; Lombard C; Enarson DA; Beyers N
Pediatrics; 2006 Nov; 118(5):e1350-9. PubMed ID: 17079536
[TBL] [Abstract][Full Text] [Related]
16. Cutaneous reactions to drugs in children.
Segal AR; Doherty KM; Leggott J; Zlotoff B
Pediatrics; 2007 Oct; 120(4):e1082-96. PubMed ID: 17908729
[TBL] [Abstract][Full Text] [Related]
17. Drug patch testing in systemic cutaneous drug allergy.
Barbaud A
Toxicology; 2005 Apr; 209(2):209-16. PubMed ID: 15767038
[TBL] [Abstract][Full Text] [Related]
18. Drug eruptions in children with ENT infections.
Rallis E; Balatsouras DG; Kouskoukis C; Verros C; Homsioglou E
Int J Pediatr Otorhinolaryngol; 2006 Jan; 70(1):53-7. PubMed ID: 15978677
[TBL] [Abstract][Full Text] [Related]
19. Drug eruptions: the value of oral rechallenge test and patch test.
Puavilai S; Chunharas A; Kamtavee S; Pongwiriyapanich S
J Med Assoc Thai; 2002 Feb; 85(2):263-9. PubMed ID: 12081129
[TBL] [Abstract][Full Text] [Related]
20. Procedures and methods of benefit assessments for medicines in Germany.
Bekkering GE; Kleijnen J
Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
